SCHEMBL17437441

SCHEMBL17437441

CCn1c(-n2ncnc2N)nc2cncc(-c3ccc(F)cc3)c21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
KMT2A Q03164 3/20 0.32
CYP11B1 P15538 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
MEN1 O00255 2/20 0.32
CYP11B2 P19099 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 1/20 0.32
NR3C1 P04150 1/20 0.32
CYP3A4 P08684 7/20 0.31
CYP1A2 P05177 6/20 0.31
USP2 O75604 3/20 0.31
CYP2C9 P11712 2/20 0.31
MAPK1 P28482 2/20 0.31
CYP17A1 P05093 2/20 0.31
HIF1A Q16665 1/20 0.31
RPS6KA5 O75582 2/20 0.31
HSD17B10 Q99714 1/20 0.31
USP7 Q93009 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437353 0.92 CYP11B1 (0.31) NPC1CYP11B1CYP11B2HCRTR1HCRTR2
SCHEMBL17437407 0.89 CYP1A2 (0.31) CYP11B1SMN1; SMN2CYP11B2CYP3A4CYP1A2
SCHEMBL17437344 0.89 ADORA3 (0.36) NPC1RAB9ASMN1; SMN2KDM4ECYP1A2
SCHEMBL17437315 0.89 PDE2A (0.36) CYP11B1CYP11B2TLR8
SCHEMBL17437538 0.88 CYP11B1 (0.34) CYP11B1CYP11B2KDM4EMAPTMAPK1
SCHEMBL17437397 0.88 GRIN2B (0.32) CYP11B1CYP11B2RPS6KA5
SCHEMBL17437395 0.88 DPP4 (0.36) CYP11B1CYP11B2KDM4EMAPTMAPK1
SCHEMBL17437565 0.86 TLR8 (0.35) CYP11B1CYP11B2KDM4EMAPTCYP1A2
SCHEMBL17437311 0.85 MAPT (0.34) NPC1KMT2AMEN1KDM4EMAPT
SCHEMBL17437399 0.85 KCNH2 (0.36) PIK3CDPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 NPC1 4168/4885RAB9A 2396/4885KMT2A 2059/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 NPC1 4168/4885RAB9A 2396/4885KMT2A 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.